Decision: Favourable
Study Title:
A MULTINATIONAL, PHASE 2, RANDOMISED, ADAPTIVE PROTOCOL TO EVALUATE IMMUNOGENICITY AND REACTOGENICITY OF DIFFERENT COVID-19 VACCINES ADMINISTRATION IN OLDER ADULTS ALREADY VACCINATED AGAINST SARS-COV-2 (EU-COVAT-1_AGED)
NREC Code:
22-NREC-CT-091
Decision:
Favourable
Meeting Date:
11/04/2022
Study Type:
CT application
Principal Investigator:
Professor Patrick Mallon
PI Institution:
University College Dublin
Sponsor:
University of Cologne